ArticlebioRxiv : the preprint server for biology2025
Frequent EPHA2 receptor mutations in cholangiocarcinoma disrupt receptor forward signaling supporting a tumor suppressor role.
Evodie Koutouan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.